glp 1 drug market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo Glucagon-like Peptide 1 (GLP-1) Market
Description
This is the only weight loss medication that works in the gut rather than the brain
J Endocrinol 2014;221:2937
Sotagliflozin in patients with diabetes and chronic kidney disease
10.1152/ajpendo.00073.2012 67 KadouhH.ChedidV.HalawiH.BurtonD
Savchenko LG, Digtiar NI, Selikhova LG, Kaidasheva EI, Shlykova OA, Vesnina LE, et al
In 2022, the trulicity segment is influencing the market with the largest market share during the forecast period
